Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies

Genes Chromosomes and Cancer

Volumn 49, Issue 10, 2010, Pages 935-947

  Vieira, Joana ^a   Henrique, Rui ^a,b   Ribeiro, Franclim R ^a   Barros Silva, João D ^a   Peixoto, Ana ^a   Santos, Catarina ^a   Pinheiro, Manuela ^a   Costa, Vera L ^a   Soares, Maria J ^a   Oliveira, Jorge ^a   Jerónimo, Carmen ^a,b   Teixeira, Manuel R ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

VON HIPPEL LINDAU PROTEIN;

ARTICLE; ASPIRATION BIOPSY; CLINICAL EVALUATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; EXON; FEASIBILITY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY CELL; KIDNEY TUMOR; MAJOR CLINICAL STUDY; NEPHRECTOMY; ONCOCYTOMA; PREDICTIVE VALIDITY; PRIORITY JOURNAL; TUMOR CELL;

ADENOMA, OXYPHILIC; BIOPSY, FINE-NEEDLE; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSIS, DIFFERENTIAL; DNA METHYLATION; EXONS; FEASIBILITY STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; NEOPLASM STAGING; NEPHRECTOMY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POINT MUTATION; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 77957877009     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20805     Document Type: Article

References (41)

1. Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M. 2002. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 26:281-291.
2. Barocas DA, Mathew S, DelPizzo JJ, Vaughan ED, Jr, Sosa RE, Fine RG, Akhtar M, Scherr DS. 2007. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int 99:290-295.
3. Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L. 2005. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol 18:161-169.
4. Bugert P, Gaul C, Weber K, Herbers J, Akhtar M, Ljungberg B, Kovacs G. 1997. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 76:203-208.
5. Cheng L, Zhang S, MacLennan GT, Lopez-Beltran A, Montironi R. 2009. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol 40:10-29.
6. Davis IJ, Hsi BL, Arroyo JD, Vargas SO, Yeh YA, Motyckova G, Valencia P, Perez-Atayde AR, Argani P, Ladanyi M, Fletcher JA, Fisher DE. 2003. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA 100:6051-6056.
7. Dechet CB, Zincke H, Sebo TJ, King BF, LeRoy AJ, Farrow GM, Blute ML. 2003. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol 169:71-74.
8. Fuzesi L, Frank D, Nguyen C, Ringert RH, Bartels H, Gunawan B. 2005. Losses of 1p and chromosome 14 in renal oncocytomas. Cancer Genet Cytogenet 160:120-125.
9. Garcia-Solano J, Acosta-Ortega J, Perez-Guillermo M, Benedicto-Orovitg JM, Jimenez-Penick FJ. 2008. Solid renal masses in adults: Image-guided fine-needle aspiration cytology and imaging techniques-"Two heads better than one?" Diagn Cytopathol 36:8-12.
10. Gerharz CD, Moll R, Storkel S, Ramp U, Hildebrandt B, Molsberger G, Koldovsky P, Gabbert HE. 1995. Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. Am J Pathol 146: 953-962.
11. Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, Zhang S, Brunelli M, Cheng L. 2008. Clear cell papillary renal cell carcinoma: A distinct histopathologic and molecular genetic entity. Am J Surg Pathol 32:1239-1245.
12. Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV. 2005. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: A retrospective nation-wide study of 629 patients. Eur Urol 48:593-600.
13. Gunawan B, von Heydebreck A, Fritsch T, Huber W, Ringert RH, Jakse G, Fuzesi L. 2003. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: Evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res 63:6200-6205.
14. Henke RP, Erbersdobler A. 2002. Numerical chromosomal aberrations in papillary renal cortical tumors: Relationship with histopathologic features. Virchows Arch 440:604-609.
15. Herr HW. 2008. Surgical management of renal tumors: A historical perspective. Urol Clin North Am 35:543-549.
16. Iqbal MA, Akhtar M, Ali MA. 1996. Cytogenetic findings in renal cell carcinoma. Hum Pathol 27:949-954.
17. ISCN. 2005. An International System for Human Cytogenetic Nomenclature. Switzerland: Karger S. Basel.
18. Jeuken JW, Cornelissen SJ, Vriezen M, Dekkers MM, Errami A, Sijben A, Boots-Sprenger SH, Wesseling P. 2007. MS-MLPA: An attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hyper-methylation in gliomas. Lab Invest 87:1055-1065.
19. Jhang JS, Narayan G, Murty VV, Mansukhani MM. 2004. Renal oncocytomas with 11q13 rearrangements: Cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Cancer Genet Cytogenet 149:114-119.
20. Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H. 2000. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 60:6503-6509.
21. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
22. Kirchhoff M, Gerdes T, Rose H, Maahr J, Ottesen AM, Lundsteen C. 1998. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31:163-173.
23. Kummerlin IP, Smedts F, Ten Kate FJ, Horn T, Algaba F, Trias I, Wijkstra H, de la Rosette JJ, Laguna MP. 2009. Cytological punctures in the diagnosis of renal tumours: A study on accuracy and reproducibility. Eur Urol 55:187-195.
24. Lebret T, Poulain JE, Molinie V, Herve JM, Denoux Y, Guth A, Scherrer A, Botto H. 2007. Percutaneous core biopsy for renal masses: Indications, accuracy and results. J Urol 178:1184-1188.
25. Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG. 2007. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: An optimal and practical panel for differential diagnosis. Arch Pathol Lab Med 131:1290-1297.
26. Masoom S, Venkataraman G, Jensen J, Flanigan RC, Wojcik EM. 2009. Renal FNA-based typing of renal masses remains a useful adjunctive modality: Evaluation of 31 renal masses with correlative histology. Cytopathology 20:50-55.
27. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. 2004. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol 171:1802-1805.
28. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guille F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ. 2005. Prognostic value of histologic subtypes in renal cell carcinoma: A multicenter experience. J Clin Oncol 23:2763-2771.
29. Receveur AO, Couturier J, Molinie V, Vieillefond A, Desangles F, Guillaud-Bataille M, Danglot G, Coullin P, Bernheim A. 2005. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization. Cancer Genet Cytogenet 158:110-118.
30. Renshaw AA, Lee KR, Madge R, Granter SR. 1997. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. Acta Cytol 41:987-994.
31. Reutzel D, Mende M, Naumann S, Storkel S, Brenner W, Zabel B, Decker J. 2001. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization. Cytogenet Cell Genet 93:221-227.
32. Ribeiro FR, Jeronimo C, Henrique R, Fonseca D, Oliveira J, Lothe RA, Teixeira MR. 2006. 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Clin Cancer Res 12:3961-3970.
33. Ribeiro FR, Henrique R, Martins AT, Jeronimo C, Teixeira MR. 2007. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Eur Urol 52:116-125.
34. Shannon BA, Cohen RJ, de Bruto H, Davies RJ. 2008. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J Urol 180:1257-1261.
35. Speicher MR, Schoell B, du Manoir S, Schrock E, Ried T, Cremer T, Storkel S, Kovacs A, Kovacs G. 1994. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145:356-364.
36. Teixeira MR. 2006. Recurrent fusion oncogenes in carcinomas. Crit Rev Oncog 12:257-271.
37. Truong LD, Todd TD, Dhurandhar B, Ramzy I. 1999. Fine-needle aspiration of renal masses in adults: Analysis of results and diagnostic problems in 108 cases. Diagn Cytopathol 20: 339-349.
38. Volpe A, Kachura JR, Geddie WR, Evans AJ, Gharajeh A, Saravanan A, Jewett MA. 2007. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol 178:379-386.
39. Wunderlich H, Hindermann W, Al Mustafa AM, Reichelt O, Junker K, Schubert J. 2005. The accuracy of 250 fine needle biopsies of renal tumors. J Urol 174:44-46.
40. Young AN, Dale J, Yin-Goen Q, Harris WB, Petros JA, Datta MW, Wang MD, Marshall FF, Amin MB. 2006. Current trends in molecular classification of adult renal tumors. Urology 67:873-880.
41. Zanssen S, Gunawan B, Fuzesi L, Warburton D, Schon EA. 2004. Renal oncocytomas with rearrangements involving 11q13 contain breakpoints near CCND1. Cancer Genet Cytogenet 149:120-124.